Here are five insights:
1. The femoral knee replacement device is in the pre-market phase.
2. The knee will be on display at the 2016 Annual Association of Orthopedic Surgeons Meeting, March 3 to March 5.
3. The companies have undertaken extensive lab testing and are now planning international clinical trials to further evaluate and test this product.
4. Maxx Orthopedics designs, develops and supplies joint replacement products.
5. Invibio pioneers PEEK-OPTIMA-based medical device solutions.
More articles on devices and implants:
After strong year-end financials, Wright Medical’s share price spikes 3.8%: 4 points
Anika Therapeutics to enter $25M share repurchase program: 3 things to know
Analysts weigh in on LDR shares — 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
